nodes	percent_of_prediction	percent_of_DWPC	metapath
Salmeterol—Viral diarrhoea—Metformin—metabolic syndrome X	0.0818	0.0988	CcSEcCtD
Salmeterol—Sinus headache—Metformin—metabolic syndrome X	0.0655	0.0791	CcSEcCtD
Salmeterol—Sinus congestion—Metformin—metabolic syndrome X	0.0429	0.0518	CcSEcCtD
Salmeterol—Toothache—Metformin—metabolic syndrome X	0.0351	0.0424	CcSEcCtD
Salmeterol—Upset stomach—Metformin—metabolic syndrome X	0.0326	0.0393	CcSEcCtD
Salmeterol—Heartburn—Metformin—metabolic syndrome X	0.031	0.0375	CcSEcCtD
Salmeterol—Rhinorrhoea—Metformin—metabolic syndrome X	0.0264	0.0318	CcSEcCtD
Salmeterol—Contusion—Metformin—metabolic syndrome X	0.0245	0.0295	CcSEcCtD
Salmeterol—Chest discomfort—Metformin—metabolic syndrome X	0.0241	0.0291	CcSEcCtD
Salmeterol—Ear pain—Metformin—metabolic syndrome X	0.0182	0.0219	CcSEcCtD
Salmeterol—Nasal congestion—Metformin—metabolic syndrome X	0.017	0.0205	CcSEcCtD
Salmeterol—Injury—Metformin—metabolic syndrome X	0.0169	0.0204	CcSEcCtD
Salmeterol—Pain in extremity—Metformin—metabolic syndrome X	0.0155	0.0187	CcSEcCtD
Salmeterol—Migraine—Metformin—metabolic syndrome X	0.0153	0.0184	CcSEcCtD
Salmeterol—Abdominal pain upper—Metformin—metabolic syndrome X	0.0142	0.0171	CcSEcCtD
Salmeterol—Cramp muscle—Metformin—metabolic syndrome X	0.014	0.0168	CcSEcCtD
Salmeterol—Nasopharyngitis—Metformin—metabolic syndrome X	0.0139	0.0167	CcSEcCtD
Salmeterol—Influenza—Metformin—metabolic syndrome X	0.0134	0.0162	CcSEcCtD
Salmeterol—Abdominal discomfort—Metformin—metabolic syndrome X	0.0128	0.0155	CcSEcCtD
Salmeterol—Upper respiratory tract infection—Metformin—metabolic syndrome X	0.0125	0.015	CcSEcCtD
Salmeterol—Infestation NOS—Metformin—metabolic syndrome X	0.0119	0.0144	CcSEcCtD
Salmeterol—Infestation—Metformin—metabolic syndrome X	0.0119	0.0144	CcSEcCtD
Salmeterol—Rhinitis—Metformin—metabolic syndrome X	0.0108	0.013	CcSEcCtD
Salmeterol—Connective tissue disorder—Metformin—metabolic syndrome X	0.0105	0.0127	CcSEcCtD
Salmeterol—Cardiac disorder—Metformin—metabolic syndrome X	0.00995	0.012	CcSEcCtD
Salmeterol—Immune system disorder—Metformin—metabolic syndrome X	0.00969	0.0117	CcSEcCtD
Salmeterol—Mediastinal disorder—Metformin—metabolic syndrome X	0.00966	0.0117	CcSEcCtD
Salmeterol—Malnutrition—Metformin—metabolic syndrome X	0.00934	0.0113	CcSEcCtD
Salmeterol—Muscle spasms—Metformin—metabolic syndrome X	0.00898	0.0108	CcSEcCtD
Salmeterol—Tremor—Metformin—metabolic syndrome X	0.00875	0.0106	CcSEcCtD
Salmeterol—Ill-defined disorder—Metformin—metabolic syndrome X	0.00866	0.0105	CcSEcCtD
Salmeterol—Malaise—Metformin—metabolic syndrome X	0.00842	0.0102	CcSEcCtD
Salmeterol—Palpitations—Metformin—metabolic syndrome X	0.00825	0.00996	CcSEcCtD
Salmeterol—Hypertension—Metformin—metabolic syndrome X	0.00806	0.00973	CcSEcCtD
Salmeterol—Chest pain—Metformin—metabolic syndrome X	0.00795	0.00959	CcSEcCtD
Salmeterol—Myalgia—Metformin—metabolic syndrome X	0.00795	0.00959	CcSEcCtD
Salmeterol—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.00789	0.00953	CcSEcCtD
Salmeterol—Discomfort—Metformin—metabolic syndrome X	0.00785	0.00948	CcSEcCtD
Salmeterol—Oedema—Metformin—metabolic syndrome X	0.00762	0.0092	CcSEcCtD
Salmeterol—Infection—Metformin—metabolic syndrome X	0.00757	0.00914	CcSEcCtD
Salmeterol—Nervous system disorder—Metformin—metabolic syndrome X	0.00747	0.00902	CcSEcCtD
Salmeterol—Skin disorder—Metformin—metabolic syndrome X	0.0074	0.00893	CcSEcCtD
Salmeterol—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.00694	0.00838	CcSEcCtD
Salmeterol—Paraesthesia—Metformin—metabolic syndrome X	0.00684	0.00826	CcSEcCtD
Salmeterol—Dyspnoea—Metformin—metabolic syndrome X	0.00679	0.0082	CcSEcCtD
Salmeterol—Dyspepsia—Metformin—metabolic syndrome X	0.00671	0.0081	CcSEcCtD
Salmeterol—Fatigue—Metformin—metabolic syndrome X	0.00657	0.00793	CcSEcCtD
Salmeterol—Constipation—Metformin—metabolic syndrome X	0.00652	0.00786	CcSEcCtD
Salmeterol—Feeling abnormal—Metformin—metabolic syndrome X	0.00628	0.00758	CcSEcCtD
Salmeterol—Gastrointestinal pain—Metformin—metabolic syndrome X	0.00623	0.00752	CcSEcCtD
Salmeterol—Urticaria—Metformin—metabolic syndrome X	0.00605	0.00731	CcSEcCtD
Salmeterol—Abdominal pain—Metformin—metabolic syndrome X	0.00602	0.00727	CcSEcCtD
Salmeterol—Asthenia—Metformin—metabolic syndrome X	0.00547	0.0066	CcSEcCtD
Salmeterol—Diarrhoea—Metformin—metabolic syndrome X	0.00521	0.00629	CcSEcCtD
Salmeterol—Dizziness—Metformin—metabolic syndrome X	0.00504	0.00608	CcSEcCtD
Salmeterol—Vomiting—Metformin—metabolic syndrome X	0.00484	0.00585	CcSEcCtD
Salmeterol—Rash—Metformin—metabolic syndrome X	0.0048	0.0058	CcSEcCtD
Salmeterol—Dermatitis—Metformin—metabolic syndrome X	0.0048	0.00579	CcSEcCtD
Salmeterol—Headache—Metformin—metabolic syndrome X	0.00477	0.00576	CcSEcCtD
Salmeterol—Nausea—Metformin—metabolic syndrome X	0.00453	0.00546	CcSEcCtD
Salmeterol—ADRB2—GPCRs, Class A Rhodopsin-like—CNR1—metabolic syndrome X	0.000588	0.00343	CbGpPWpGaD
Salmeterol—CYP2C8—Arachidonic acid metabolism—PTGS2—metabolic syndrome X	0.00058	0.00338	CbGpPWpGaD
Salmeterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2C—metabolic syndrome X	0.000561	0.00327	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—MTNR1B—metabolic syndrome X	0.000549	0.0032	CbGpPWpGaD
Salmeterol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—metabolic syndrome X	0.000539	0.00314	CbGpPWpGaD
Salmeterol—CYP3A5—Biological oxidations—GGT1—metabolic syndrome X	0.000536	0.00312	CbGpPWpGaD
Salmeterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—GHRL—metabolic syndrome X	0.000532	0.0031	CbGpPWpGaD
Salmeterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CNR1—metabolic syndrome X	0.000504	0.00294	CbGpPWpGaD
Salmeterol—CYP2C8—Biological oxidations—GGT1—metabolic syndrome X	0.000464	0.00271	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—EPHX2—metabolic syndrome X	0.000462	0.00269	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—HTR2C—metabolic syndrome X	0.000427	0.00249	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—GHRL—metabolic syndrome X	0.000405	0.00236	CbGpPWpGaD
Salmeterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL5—metabolic syndrome X	0.00039	0.00228	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—CNR1—metabolic syndrome X	0.000384	0.00224	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—FABP4—metabolic syndrome X	0.000369	0.00215	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—FMO3—metabolic syndrome X	0.000369	0.00215	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—HSD11B1—metabolic syndrome X	0.00035	0.00204	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—MLXIPL—metabolic syndrome X	0.000329	0.00192	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—EPHX2—metabolic syndrome X	0.000329	0.00192	CbGpPWpGaD
Salmeterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGT—metabolic syndrome X	0.000327	0.0019	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—MTNR1B—metabolic syndrome X	0.00031	0.00181	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—G6PC2—metabolic syndrome X	0.000309	0.0018	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—HDAC3—metabolic syndrome X	0.000305	0.00178	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—LPA—metabolic syndrome X	0.000298	0.00174	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—CCL5—metabolic syndrome X	0.000297	0.00173	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G6—metabolic syndrome X	0.000288	0.00168	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—APOA5—metabolic syndrome X	0.000286	0.00166	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—MTNR1B—metabolic syndrome X	0.000282	0.00164	CbGpPWpGaD
Salmeterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—metabolic syndrome X	0.000269	0.00157	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—FMO3—metabolic syndrome X	0.000267	0.00155	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—TRIB3—metabolic syndrome X	0.000265	0.00155	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—FABP4—metabolic syndrome X	0.000263	0.00153	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—HSD11B1—metabolic syndrome X	0.000249	0.00145	CbGpPWpGaD
Salmeterol—CYP3A4—Biological oxidations—GGT1—metabolic syndrome X	0.000249	0.00145	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—AGT—metabolic syndrome X	0.000249	0.00145	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—HTR2C—metabolic syndrome X	0.000242	0.00141	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—MLXIPL—metabolic syndrome X	0.000238	0.00139	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—EPHX2—metabolic syndrome X	0.000238	0.00139	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—LIPC—metabolic syndrome X	0.000237	0.00138	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—APOC3—metabolic syndrome X	0.000235	0.00137	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—FMO3—metabolic syndrome X	0.000231	0.00135	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—GHRL—metabolic syndrome X	0.000229	0.00133	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—CETP—metabolic syndrome X	0.000228	0.00133	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—G6PC2—metabolic syndrome X	0.000223	0.0013	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—G6PD—metabolic syndrome X	0.000222	0.00129	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—HTR2C—metabolic syndrome X	0.000219	0.00128	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—SCARB1—metabolic syndrome X	0.000219	0.00127	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—CNR1—metabolic syndrome X	0.000217	0.00126	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—HDAC3—metabolic syndrome X	0.000217	0.00126	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—SREBF1—metabolic syndrome X	0.000212	0.00124	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—GCKR—metabolic syndrome X	0.000212	0.00123	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—LPA—metabolic syndrome X	0.000212	0.00123	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—GHRL—metabolic syndrome X	0.000208	0.00121	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—HMGCR—metabolic syndrome X	0.000206	0.0012	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—MLXIPL—metabolic syndrome X	0.000206	0.0012	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—EPHX2—metabolic syndrome X	0.000206	0.0012	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—PLA2G6—metabolic syndrome X	0.000205	0.0012	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—CCL2—metabolic syndrome X	0.000205	0.00119	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—APOA5—metabolic syndrome X	0.000203	0.00118	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—CNR1—metabolic syndrome X	0.000197	0.00115	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—G6PC2—metabolic syndrome X	0.000194	0.00113	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—FABP4—metabolic syndrome X	0.00019	0.00111	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—TRIB3—metabolic syndrome X	0.000189	0.0011	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—HDAC3—metabolic syndrome X	0.000186	0.00108	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—metabolic syndrome X	0.000184	0.00107	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—HSD11B1—metabolic syndrome X	0.00018	0.00105	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—metabolic syndrome X	0.000178	0.00104	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—NAMPT—metabolic syndrome X	0.000169	0.000987	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—LIPC—metabolic syndrome X	0.000168	0.000981	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—GCK—metabolic syndrome X	0.000168	0.000981	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—CCL5—metabolic syndrome X	0.000168	0.00098	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—APOC3—metabolic syndrome X	0.000167	0.000975	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—MTNR1B—metabolic syndrome X	0.000166	0.000969	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—FABP4—metabolic syndrome X	0.000165	0.000959	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—CETP—metabolic syndrome X	0.000162	0.000947	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—TRIB3—metabolic syndrome X	0.000162	0.000945	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—RBP4—metabolic syndrome X	0.000162	0.000945	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—G6PD—metabolic syndrome X	0.000161	0.000936	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—HDAC3—metabolic syndrome X	0.000157	0.000913	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—HSD11B1—metabolic syndrome X	0.000156	0.000909	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—SCARB1—metabolic syndrome X	0.000155	0.000906	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—LPA—metabolic syndrome X	0.000153	0.000893	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—GCKR—metabolic syndrome X	0.000153	0.000893	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—CCL5—metabolic syndrome X	0.000153	0.00089	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.000152	0.000886	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—APOB—metabolic syndrome X	0.000151	0.000882	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—SREBF1—metabolic syndrome X	0.000151	0.00088	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—PLA2G6—metabolic syndrome X	0.000148	0.000865	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—metabolic syndrome X	0.000147	0.000858	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—GOT2—metabolic syndrome X	0.000147	0.000856	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—HMGCR—metabolic syndrome X	0.000147	0.000856	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—APOA5—metabolic syndrome X	0.000147	0.000856	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	0.000144	0.000842	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—APOC3—metabolic syndrome X	0.000144	0.000837	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—AGT—metabolic syndrome X	0.000141	0.000819	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—G6PD—metabolic syndrome X	0.000139	0.000811	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	0.000137	0.0008	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—TRIB3—metabolic syndrome X	0.000136	0.000796	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—HDAC3—metabolic syndrome X	0.000136	0.000791	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—GCKR—metabolic syndrome X	0.000133	0.000773	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—LPA—metabolic syndrome X	0.000133	0.000773	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—ABCA1—metabolic syndrome X	0.000131	0.000763	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—SLC2A4—metabolic syndrome X	0.000131	0.000763	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—HTR2C—metabolic syndrome X	0.00013	0.000755	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—PLA2G6—metabolic syndrome X	0.000128	0.000749	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—AGT—metabolic syndrome X	0.000128	0.000744	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	0.000128	0.000744	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—APOA5—metabolic syndrome X	0.000127	0.000741	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—GGT1—metabolic syndrome X	0.000127	0.000739	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—GOT1—metabolic syndrome X	0.000127	0.000739	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CYBA—metabolic syndrome X	0.000125	0.000731	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—FMO3—metabolic syndrome X	0.000124	0.000723	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	0.000124	0.00072	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—GHRL—metabolic syndrome X	0.000123	0.000716	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—NAMPT—metabolic syndrome X	0.000122	0.000714	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—LIPC—metabolic syndrome X	0.000122	0.000709	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—GCK—metabolic syndrome X	0.000122	0.000709	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	0.000121	0.000706	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—APOC3—metabolic syndrome X	0.000121	0.000705	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	0.00012	0.000697	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—TRIB3—metabolic syndrome X	0.000118	0.000689	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—CETP—metabolic syndrome X	0.000117	0.000684	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CNR1—metabolic syndrome X	0.000116	0.000678	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—SCARB1—metabolic syndrome X	0.000112	0.000655	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—MLXIPL—metabolic syndrome X	0.00011	0.000644	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—EPHX2—metabolic syndrome X	0.00011	0.000644	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—SREBF1—metabolic syndrome X	0.000109	0.000636	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—APOB—metabolic syndrome X	0.000108	0.000627	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—HMGCR—metabolic syndrome X	0.000106	0.000619	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—GOT2—metabolic syndrome X	0.000106	0.000619	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—NAMPT—metabolic syndrome X	0.000106	0.000618	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	0.000105	0.000615	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—GCK—metabolic syndrome X	0.000105	0.000614	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—LIPC—metabolic syndrome X	0.000105	0.000614	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—CCL2—metabolic syndrome X	0.000105	0.000613	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—APOC3—metabolic syndrome X	0.000105	0.00061	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—PLA2G4A—metabolic syndrome X	0.000105	0.00061	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—G6PC2—metabolic syndrome X	0.000104	0.000606	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—LPL—metabolic syndrome X	0.000103	0.000599	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—CETP—metabolic syndrome X	0.000102	0.000593	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—CD36—metabolic syndrome X	9.76e-05	0.000569	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—SCARB1—metabolic syndrome X	9.74e-05	0.000568	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—IGF2—metabolic syndrome X	9.51e-05	0.000554	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	9.48e-05	0.000553	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—ABCA1—metabolic syndrome X	9.46e-05	0.000552	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—SLC2A4—metabolic syndrome X	9.46e-05	0.000552	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—SREBF1—metabolic syndrome X	9.45e-05	0.000551	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—APOB—metabolic syndrome X	9.23e-05	0.000538	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—HMGCR—metabolic syndrome X	9.19e-05	0.000536	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—GOT2—metabolic syndrome X	9.19e-05	0.000536	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—GGT1—metabolic syndrome X	9.16e-05	0.000534	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—GOT1—metabolic syndrome X	9.16e-05	0.000534	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—PPARA—metabolic syndrome X	9.07e-05	0.000529	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CCL5—metabolic syndrome X	9.01e-05	0.000525	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—PLA2G4A—metabolic syndrome X	8.98e-05	0.000523	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—FABP4—metabolic syndrome X	8.83e-05	0.000515	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—LPL—metabolic syndrome X	8.81e-05	0.000514	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—AGT—metabolic syndrome X	8.79e-05	0.000512	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—APOE—metabolic syndrome X	8.61e-05	0.000502	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—APOA1—metabolic syndrome X	8.51e-05	0.000496	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—HSD11B1—metabolic syndrome X	8.37e-05	0.000488	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	8.29e-05	0.000483	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—ABCA1—metabolic syndrome X	8.19e-05	0.000478	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—SLC2A4—metabolic syndrome X	8.19e-05	0.000478	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—GOT1—metabolic syndrome X	7.94e-05	0.000463	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—GGT1—metabolic syndrome X	7.94e-05	0.000463	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—APOB—metabolic syndrome X	7.77e-05	0.000453	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—PLA2G4A—metabolic syndrome X	7.56e-05	0.000441	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—AGT—metabolic syndrome X	7.54e-05	0.00044	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—PPARG—metabolic syndrome X	7.5e-05	0.000437	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—G6PD—metabolic syndrome X	7.46e-05	0.000435	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—LPL—metabolic syndrome X	7.42e-05	0.000433	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—APOE—metabolic syndrome X	7.39e-05	0.000431	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—LEP—metabolic syndrome X	7.39e-05	0.000431	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—INS—metabolic syndrome X	7.35e-05	0.000429	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—APOA1—metabolic syndrome X	7.3e-05	0.000426	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—HDAC3—metabolic syndrome X	7.28e-05	0.000425	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—GCKR—metabolic syndrome X	7.12e-05	0.000415	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—LPA—metabolic syndrome X	7.12e-05	0.000415	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—CD36—metabolic syndrome X	7.05e-05	0.000411	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PLA2G6—metabolic syndrome X	6.9e-05	0.000402	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—APOA5—metabolic syndrome X	6.83e-05	0.000398	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—ALB—metabolic syndrome X	6.74e-05	0.000393	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—APOB—metabolic syndrome X	6.73e-05	0.000393	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—IRS1—metabolic syndrome X	6.59e-05	0.000384	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—PPARA—metabolic syndrome X	6.56e-05	0.000382	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—PLA2G4A—metabolic syndrome X	6.55e-05	0.000382	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—NOS3—metabolic syndrome X	6.45e-05	0.000376	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—LPL—metabolic syndrome X	6.43e-05	0.000375	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—AGT—metabolic syndrome X	6.35e-05	0.00037	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—TRIB3—metabolic syndrome X	6.35e-05	0.00037	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—INS—metabolic syndrome X	6.31e-05	0.000368	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—APOE—metabolic syndrome X	6.22e-05	0.000363	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CCL2—metabolic syndrome X	6.21e-05	0.000362	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—APOA1—metabolic syndrome X	6.15e-05	0.000359	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—CD36—metabolic syndrome X	6.11e-05	0.000356	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—IGF1—metabolic syndrome X	6.11e-05	0.000356	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—PTGS2—metabolic syndrome X	5.9e-05	0.000344	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—SERPINE1—metabolic syndrome X	5.8e-05	0.000338	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—NAMPT—metabolic syndrome X	5.69e-05	0.000332	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—PPARA—metabolic syndrome X	5.68e-05	0.000331	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—LIPC—metabolic syndrome X	5.66e-05	0.00033	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—GCK—metabolic syndrome X	5.66e-05	0.00033	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—APOC3—metabolic syndrome X	5.62e-05	0.000328	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—NOS3—metabolic syndrome X	5.54e-05	0.000323	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—AGT—metabolic syndrome X	5.5e-05	0.000321	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—CETP—metabolic syndrome X	5.46e-05	0.000318	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—PPARG—metabolic syndrome X	5.42e-05	0.000316	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—APOE—metabolic syndrome X	5.39e-05	0.000314	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—APOA1—metabolic syndrome X	5.33e-05	0.000311	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—INS—metabolic syndrome X	5.32e-05	0.00031	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—SCARB1—metabolic syndrome X	5.23e-05	0.000305	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—SREBF1—metabolic syndrome X	5.07e-05	0.000296	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—HMGCR—metabolic syndrome X	4.93e-05	0.000288	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—GOT2—metabolic syndrome X	4.93e-05	0.000288	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—ALB—metabolic syndrome X	4.87e-05	0.000284	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—AKT1—metabolic syndrome X	4.74e-05	0.000277	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—PPARG—metabolic syndrome X	4.69e-05	0.000274	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—IL6—metabolic syndrome X	4.67e-05	0.000272	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—NOS3—metabolic syndrome X	4.66e-05	0.000272	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—INS—metabolic syndrome X	4.6e-05	0.000268	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—ABCA1—metabolic syndrome X	4.4e-05	0.000256	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—SLC2A4—metabolic syndrome X	4.4e-05	0.000256	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—AKT1—metabolic syndrome X	4.31e-05	0.000251	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—PTGS2—metabolic syndrome X	4.26e-05	0.000249	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—GGT1—metabolic syndrome X	4.26e-05	0.000248	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—GOT1—metabolic syndrome X	4.26e-05	0.000248	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—ALB—metabolic syndrome X	4.22e-05	0.000246	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—NOS3—metabolic syndrome X	4.04e-05	0.000235	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—PTGS2—metabolic syndrome X	3.69e-05	0.000215	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—TGFB1—metabolic syndrome X	3.66e-05	0.000213	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—APOB—metabolic syndrome X	3.61e-05	0.000211	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PLA2G4A—metabolic syndrome X	3.52e-05	0.000205	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—LPL—metabolic syndrome X	3.45e-05	0.000201	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—CD36—metabolic syndrome X	3.28e-05	0.000191	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PPARA—metabolic syndrome X	3.05e-05	0.000178	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—AKT1—metabolic syndrome X	2.96e-05	0.000173	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—AGT—metabolic syndrome X	2.95e-05	0.000172	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—APOE—metabolic syndrome X	2.89e-05	0.000169	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—APOA1—metabolic syndrome X	2.86e-05	0.000167	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—IL6—metabolic syndrome X	2.76e-05	0.000161	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—AKT1—metabolic syndrome X	2.54e-05	0.000148	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PPARG—metabolic syndrome X	2.52e-05	0.000147	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—INS—metabolic syndrome X	2.47e-05	0.000144	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—ALB—metabolic syndrome X	2.27e-05	0.000132	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—NOS3—metabolic syndrome X	2.17e-05	0.000126	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—AKT1—metabolic syndrome X	2.14e-05	0.000125	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PTGS2—metabolic syndrome X	1.98e-05	0.000116	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—AKT1—metabolic syndrome X	1.86e-05	0.000108	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—AKT1—metabolic syndrome X	9.96e-06	5.81e-05	CbGpPWpGaD
